Dan Brennan
Stock Analyst at TD Cowen
(4.42)
# 327
Out of 5,090 analysts
120
Total ratings
56.84%
Success rate
18%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXH MDxHealth | Maintains: Buy | $5 → $7 | $3.60 | +94.44% | 2 | Nov 13, 2025 | |
| WAT Waters | Maintains: Hold | $345 → $390 | $394.81 | -1.22% | 4 | Nov 5, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $74 → $90 | $101.06 | -10.94% | 7 | Nov 4, 2025 | |
| MYGN Myriad Genetics | Maintains: Hold | $8 → $9 | $7.09 | +26.94% | 2 | Nov 4, 2025 | |
| BRKR Bruker | Maintains: Hold | $40 → $42 | $48.03 | -12.55% | 2 | Nov 4, 2025 | |
| ILMN Illumina | Maintains: Hold | $110 → $115 | $128.96 | -10.83% | 13 | Oct 31, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $612 → $654 | $572.77 | +14.18% | 13 | Oct 23, 2025 | |
| DHR Danaher | Maintains: Buy | $250 → $260 | $226.25 | +14.92% | 6 | Oct 22, 2025 | |
| A Agilent Technologies | Maintains: Buy | $150 → $162 | $145.49 | +11.35% | 13 | Oct 14, 2025 | |
| GH Guardant Health | Maintains: Buy | $63 → $72 | $102.02 | -29.43% | 3 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $11.90 | +0.84% | 7 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $14.75 | +1.69% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $28.86 | +10.88% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $110 | $158.96 | -30.80% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $2.5 | $3.70 | -32.43% | 4 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $74 | $76.66 | -3.47% | 2 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $175 | $244.55 | -28.44% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $250 | $184.31 | +35.64% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $141 → $144 | $100.79 | +42.87% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $10.93 | +183.62% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $41.69 | +22.33% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $56 | $7.68 | +629.64% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $17.77 | +80.08% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $190.01 | +187.35% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $2.39 | +527.62% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $185.80 | +24.87% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,414.86 | -37.80% | 3 | Oct 7, 2020 |
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $3.60
Upside: +94.44%
Waters
Nov 5, 2025
Maintains: Hold
Price Target: $345 → $390
Current: $394.81
Upside: -1.22%
Exact Sciences
Nov 4, 2025
Maintains: Buy
Price Target: $74 → $90
Current: $101.06
Upside: -10.94%
Myriad Genetics
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $9
Current: $7.09
Upside: +26.94%
Bruker
Nov 4, 2025
Maintains: Hold
Price Target: $40 → $42
Current: $48.03
Upside: -12.55%
Illumina
Oct 31, 2025
Maintains: Hold
Price Target: $110 → $115
Current: $128.96
Upside: -10.83%
Thermo Fisher Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $612 → $654
Current: $572.77
Upside: +14.18%
Danaher
Oct 22, 2025
Maintains: Buy
Price Target: $250 → $260
Current: $226.25
Upside: +14.92%
Agilent Technologies
Oct 14, 2025
Maintains: Buy
Price Target: $150 → $162
Current: $145.49
Upside: +11.35%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $63 → $72
Current: $102.02
Upside: -29.43%
Sep 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $11.90
Upside: +0.84%
Aug 6, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $14.75
Upside: +1.69%
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $28.86
Upside: +10.88%
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $158.96
Upside: -30.80%
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $3.70
Upside: -32.43%
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $76.66
Upside: -3.47%
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $244.55
Upside: -28.44%
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $184.31
Upside: +35.64%
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $100.79
Upside: +42.87%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $10.93
Upside: +183.62%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $41.69
Upside: +22.33%
May 13, 2024
Initiates: Buy
Price Target: $56
Current: $7.68
Upside: +629.64%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $17.77
Upside: +80.08%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $190.01
Upside: +187.35%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $2.39
Upside: +527.62%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $185.80
Upside: +24.87%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,414.86
Upside: -37.80%